Files Patent Covering its Proprietary Cancer Vaccine

Batu Biologics Files Patent Covering its Proprietary Cancer Vaccine Targeting the Tumor Endothelium: Vallovax
Animal Studies Demonstrate Efficacy in Treatment of Non-Small Cell Lung Cancer

Angiogenesis has proven to be a key factor in the proliferation of tumor cells within the host. Recent studies have revealed that without the formation of new blood vessels, tumors are unable to receive the blood supply they need to grow bigger than 1 to 2 mm in diameter.

Read the full article at businesswire.com

0